本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Altimmune, Inc.

3.24
+0.01000.31%
盤後3.240.00000.00%19:49 EDT
成交量:333.18萬
成交額:1,081.27萬
市值:6.29億
市盈率:-4.26
高:3.29
開:3.27
低:3.20
收:3.23
52周最高:6.44
52周最低:2.56
股本:1.94億
流通股本:1.64億
量比:1.27
換手率:2.03%
股息:- -
股息率:- -
每股收益(TTM):-0.7600
每股收益(LYR):-0.9999
淨資產收益率:-28.87%
總資產收益率:-17.20%
市淨率:1.33
市盈率(LYR):-3.24

資料載入中...

2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/20

重要事件披露

8-K - Current report
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/29

重要事件披露

8-K - Current report
2022/09/14

重要事件披露

8-K - Current report
2022/08/11

重要事件披露

8-K - Current report
2022/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

重要事件披露

8-K - Current report
2022/03/24

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/15

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals